SEMBA BIOSCIENCES, INC.
| 505 South Rosa Rd
MADISON, WI, 53719-1262
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|
DESCRIPTION (provided by applicant): Monoclonal antibodies (mAbs) have become the leading drug class for cancer treatment, and over 150 anti-neoplastic mAbs are in the biopharmaceutical pipeline. Mos ...SBIR Phase II 2014 Department of Health and Human Services
DESCRIPTION (provided by applicant): In today's biopharmaceutical pipeline, monoclonal antibodies (mAbs) are a predominant modality for a broad range of clinical indications including oncology an ...SBIR Phase I 2012 Department of Health and Human Services
DESCRIPTION (provided by applicant): In various proteomics initiatives there is a significant effort to determine detailed molecular structures of the thousands of proteins and protein complexes that ...SBIR Phase I 2007 Department of Health and Human Services